Exagen Inc. Reports Fourth Quarter and Full Year 2019 Results
Exagen Inc. (XGN)
Last exagen inc. earnings: 3/25 04:05 pm
Check Earnings Report
Company Research
Source: GlobeNewswire
SAN DIEGO, March 25, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention, today reported financial results for the fourth quarter and full year ended December 31, 2019. Recent Highlights: Generated total revenue of $40.4 million for the year ended December 31, 2019, representing 24% year-over-year growth.Experienced record demand for the flagship AVISE® CTD test, including AVISE® Lupus, to over 105,000 tests in 2019, a 26% increase over 2018.Grew the number of ordering healthcare providers in the fourth quarter by 34% year-over-year to a record 1,707.Sequential quarter retention rate of approximately 98% among adopting healthcare providers in the fourth quarter of 2019.Advanced strategic integrated testing and therapeutics strategy (Dx/Rx) through co-promotion agreemen
Show less
Read more
Impact Snapshot
Event Time:
XGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XGN alerts
High impacting Exagen Inc. news events
Weekly update
A roundup of the hottest topics
XGN
News
- Analyst Estimates: Here's What Brokers Think Of Exagen Inc. (NASDAQ:XGN) After Its Annual Report [Yahoo! Finance]Yahoo! Finance
- Exagen Inc. (NASDAQ:XGN) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results [Yahoo! Finance]Yahoo! Finance
- Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 ResultsGlobeNewswire
- Cresco Labs Inc. (CRLBF) Q4 Earnings and Revenues Surpass Estimates [Yahoo! Finance]Yahoo! Finance
XGN
Earnings
- 3/18/24 - Beat
XGN
Sec Filings
- 3/18/24 - Form 10-K
- 3/18/24 - Form 8-K
- 3/6/24 - Form 4
- XGN's page on the SEC website